Treatment of Acute Stroke With Cromolyn(Single Dose)
- Registration Number
- NCT01175525
- Lead Sponsor
- Wolfson Medical Center
- Brief Summary
Mastocytes were proven to have a central rule in their development of the lipoid plaque of the vascular system. Mastocytes also has an important role in the stabilisation of the plaque in the building of the brain barrier. Different animal studies show that the inhibition of the mastocyte activity decreases significantly the risk of secondary bleeding post ischaemic stroke.It was also shown that post stroke inflammation process was also blocked by the inhibition of mastocytes.Other studies showed up to 100% decrease in the brain barrier disruption and post stroke oedema, after treatment with mastocyte inhibitors.
Cromolyn is a synthetic drug which has an anti-allergic effect by inhibition of the mastocytes. This drug is a well known,safe drug and is the main sub-substance that was used in the previously mentioned studies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
- Infarction of the anterior Circulation system.
- Both genders
- Age > 20 years
- NIHSS > 5 -
- Non- ischaemic stroke
- Additional disease of the CNS
- Known allergy to cromolyn
- Diseae of mastocytosis
- Renal or Hepatic failure (acute or chronic)
- Inability to sign consent form (dementia or sensory aphasia)
- Lacunar infarctions
- INfarction present in cerebellum or brain stem -
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description sugar pill sugar pill sugar pill dissolved in water to be given 4 times a day 30 minutes prior to meals Cromolyn CROMOLYN Cromolyn dose of 200mg(dissolved in water) will be given 4 times a day(30 minutes before a meal)
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Edith wolfson medical Center
🇮🇱Holon, Israel